Filing Details

Accession Number:
0001140361-17-015047
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-04-05 19:40:14
Reporting Period:
2017-04-04
Filing Date:
2017-04-05
Accepted Time:
2017-04-05 19:40:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1302573 Oncomed Pharmaceuticals Inc OMED Pharmaceutical Preparations (2834) 383572512
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1553333 Timothy Hoey C/O Oncomed Pharmaceuticals, Inc.
800 Chesapeake Drive
Redwood City CA 94063
Svp, Cancer Biology & Co-Cso No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-04-04 43 $8.87 62,936 No 4 S Direct
Common Stock Disposition 2017-04-04 5,711 $9.06 57,225 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Pursuant to a sell-to-cover election made by the Reporting Person at the time of the initial grant of the restricted stock unit award, the shares were sold upon the vesting of restricted stock units solely to cover applicable withholding taxes.
  2. Includes 12,500 restricted stock units ("RSUs"). The reporting person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof.
  3. Includes 2,000 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2017.